ABSTRACT The purpose of this study was to investigate whether adding a Chinese herbal hedicine (CHM, including astragalus membranaceus, codonopsis pilosula, poria cocos, bighead atractylodes rhizome, fructus crataegi, folium epimedii, radix saposhnikoviae, and pericarpium citri reticulatae) diet has effects on lipid metabolism in the liver of the broiler. Six-hundredthirty Hetian broilers were divided into 3 groups including base diet (control), 0.3%, or 1% CHM diets, for 130 days. The results showed that CHM treatment significantly increased the slaughter performance. CHM treatment decreased plasma triglyceride (TG) and nonesterified fatty acid (NEFA) concentrations; upregulated the expression of peroxisome proliferator activated receptor (PPAR), the transcription factor sterol regulatory element binding protein-1c (SREBP-1c) and its downstream proteins involved in NEFA oxidation including carnitine palmitoyltransferase-1, liver fatty acid binding protein, and PPARα; and it significantly decreased fatty acid synthetase, stearoyl-CoA desaturase, acyl-CoA synthetase long-chain family member 1 and acetyl-CoA carboxylase expression to inhibit NEFA synthesis. In addition, the CHM treatment increased plasma insulin (INS) levels and up-regulated insulin receptors (INSR) glycerol-3-phosphate acyltransferase and mitochondrial and 1-acylglycerol-3-phosphate Oacyltransferase 6 mRNA expression to enhance TG synthesis. The protein levels of phosphatidylinositol 3-hydroxy kinase (PI3K), serine/threonine protein kinase (Akt), S6 kinase (S6K), phospho-serine/threonine protein kinase (p-Akt), and phospho-S6 kinase (p-S6K) also were increased. PI3K, p-Akt, and p-S6K were significantly up-regulated in the liver. These data suggest that the CHM may be a beneficial compound to decrease plasma NEFA and TG levels by activating the INS/INSR-PI3K-Akt-SREBP1c pathway resulting in fat content reduction in the carcass.
INTRODUCTION
Organic and natural poultry products are popular with consumers and are attributed to good meat quality. Hetian chicken is a traditional cultivar with Chinese characteristics, important for the evaluation and utilization of resources. Hetian chicken is a slower-growing broiler genotype and is suitable for use in organic and natural poultry production. Previous studies indicated that organic broilers with less fat may be preferred by consumers (Fanatico et al., 2005) . Nonesterified fatty acids (NEFA) and triglycerides (TG) are the main precursors of fat, and it was reported that more than 40% NEFA could be used for fat synthesis (Kadegowda et al., 2008a,b; Ingraham et al., 2014 an important organ for NEFA and TG removal from the blood (Bell, 1979) . Approximately 80% of plasma NEFA is transported to the liver where they are either oxidized to generate energy in the form of ATP, or reesterified for storage as TG (Hocquette and Bauchart, 1999; van Dorland et al., 2012) . Previous studies have shown that approximately half of the fat content comes from NEFA of degraded daily rations (Smith and Abraham, 1975; Dils and Knudsen, 1980; Thompson and Smith, 1985; Qi et al., 2014; Osorio et al., 2016) . However, all of these NEFA are transported into the liver for metabolism and distribution and then leave the liver through the hepatic vein to be absorbed directly from the blood or utilized for de novo synthesis, both of which exist during the fat synthesis process in a variety of tissues. Therefore, the metabolic changes of NEFA levels in the liver have an important effect on fat synthesis.
Chinese herbal medicine (CHM) is a rarity of traditional medicine, in which effective constituents are polysaccharides, alkaloids, and oils (Olmedo et al., 2014; Otoni et al., 2014) . A series of studies indicated that the CHM, such as astragalus polysaccharide (Cao et al., 2014) and oregano extract (Kirkpinar et al., 2014) , can synergistically improve the immune efficacy and increase growth performance, metabolism, and cardiotoxicity in animals or animal cells (Chen et al., 2010; Chen et al., 2013; Kallon et al., 2013) . Especially in the metabolic processes, CHM could be regulated with the expression of insulin receptor substrate-1 and nuclear ubiquitin in glycometabolism in the liver by the alteration of p38 MAPK pathways (Ye et al., 2014) and AMPK activation . Previous studies have shown that sulfated astragalus polysaccharide increased body weight gain and jejunal villus height of birds that were injected intramuscularly with 8 mg/kg BW, and other studies have shown better slaughter performance in poultry (Guo et al., 2004; Wang et al., 2015) .
Compared to adipose tissue in mammals, lipid metabolism of poultry differs from that in mammals with the liver being the main organ involved in its metabolic activity. The abdominal fat deposition is an important part of lipid metabolism. However, a previous study has shown that this CHM (astragalus polysaccharide) could increase body weight gain and slaughter performance in poultry. The regulatory mechanism of action also was not clear. To further explore the regulatory mechanism of CHM on lipid metabolism and growth performance, the hepatic expression of lipid metabolism-related proteins/enzymes were analyzed in broiler chickens with CHM treatment.
MATERIALS AND METHODS

Animals and Experimental Model
A total of 630 day-old male Hetian broiler chickens (Changting Mountains Hetian Chicken Breeding Company) was weighed and allocated to 3 treatment groups including a base diet (control), 0.3%, or 1% CHM, including astragalus membranaceus, codonopsis pilosula, poria cocos, bighead atractylodes rhizome, fructus crataegi, folium epimedii, radix Saposhnikoviae, and pericarpium citri reticulatae) diets, each of which included 6 replicates of 35 birds. Prepared CHM was processed in conformity with national drug standards. The composition of CHM was according to the above order of medicinal materials and in the proportion of 30:20:10:10:10:10:5:5. The birds were offered the same basal diet for 130 d (starter phase, d one to 28; midphase, d 29 to 80; and finisher phase, d 81 to 130). The birds were treated with the CHM diet during the midphase and finisher phase. Dietary nutrient levels were based on National Research Council recommended nutrient requirements for broiler chickens (Yang et al., 2006) . All animal procedures were approved by the Fujian Agriculture and Forestry University Animal Care and Use Committee.
The chickens were housed in lighted coops. During the first 5 d, the temperature was set at 32
• C, and constant lighting and water were continuously provided. Then, the temperature was gradually reduced until a temperature of 22
• C was achieved, based on normal management practices. The broilers were floor-reared under natural lighting during the mid-and finisher phases and were provided an independent playground. At the end of the experiment, the chickens were deprived of feed for 12 h, weighed, and sacrificed by the random selection of 15 birds from every replicate. Plasma and livers were obtained at the time of slaughter, and then they were stored at −20
• C and −70 • C, respectively, until analyzed.
Slaughter Performance
Slaughter rate, semi-eviscerated ratio, eviscerated ratio, breast muscle rate, and thigh muscle rate were determinate by the method of China Standard NY/T823-200. The computational formula is shown as follows: (1), Slaughter rate (%) = slaughtering weight/body weight × 100%; (2), semi-eviscerated ratio (%) = semi-eviscerated weight/body weight × 100%; (3), eviscerated ratio (%) = eviscerated weight/body weight × 100%; (4), breast muscle ratio (%) = bilateral breast muscle weight/eviscerated weight × 100%; (5), thigh muscle rate (%) = bilateral thigh muscle weight/eviscerated weight × 100%.
Determination of Plasma Lipid Profile
During the 130 d, blood samples were collected in heparin sodium mining vessels and centrifuged at 3,500 rpm for 15 min to separate the plasma, which was stored at −20
• C until the analysis. The plasma TG and total cholesterol (TC) contents were detected at the Fuzhou General Hospital of Nanjing Military Region (Fuzhou, China) using a Beckman Kurt AU5800 series automatic biochemical analyzer (Beckman Kurt, Brea, California). A NEFA-ELISA kit (Lengton, Shanghai, China) was used for detecting NEFA contents according to the instruction manual.
RNA extraction, cDNA synthesis, and qPCR
Liver samples were collected at slaughter and immediately frozen in liquid nitrogen during the 130 days. Total RNA was extracted from liver tissue samples using the TRIzol reagent (Invitrogen, Carlsbad, California), and the concentration was then quantified by measuring the absorbance at 260 nm in a spectrophotometer (Eppendorf Biotechnology, Hamburg, Germany). The mRNA expression level in liver tissue was measured by qRT-PCR analysis and the 2 − Ct method. Then, 2 μg total of RNA was performed by reverse transcription in a final volume of 25 μL mixture containing 1 × RT buffer, 100 U reverse transcriptase, The abbreviation of the primer names are shown as follows: ACC: acetyl-CoA carboxylase; FAS: fatty acid synthetase; SCD: stearoylCoA desaturase; SREBP-1c: sterol regulatory element-binding protein-1c; PPARα: peroxisome proliferator activated receptor alpha; CPT-1: carnitine palmitoyltransferase-1; ACSL1: acyl-CoA synthetase long-chain family member 1; LFABP: liver fatty acid binding protein; IR: insulin receptor; IRS: insulin receptor substrates. GPAM: glycerol-3-phosphate acyltransferase, mitochondrial; AGPAT6: 1-acylglycerol-3-phosphate O-acyltransferase 6; LPIN1: Lipin 1; SPTLC1: serine palmitoyltransferase, long chain base subunit 1. 8 U RNase inhibitor (Promega, Madison), 5.3 μmol/L Oligo-dT primers, and 0.8 mmol/L dNTPs (TaKaRa, Dalian, China). The reaction of reverse transcription and qPCR was prepared on ice according to our previous study (Xie et al., 2015) and performed with MyiQ2 Real-time PCR system (Bio Rad, Hercules, California). Using Primer 5.0 software, primers were designed and then synthesized by Sangon Biotech (Shanghai, China). The conditions used in the PCR are listed in Table 1 .
SDS-PAGE and western blot analysis
Total protein was extracted from frozen liver tissue, and the protein concentration for each of the final supernatants was measured by the Bradford assay using bovine serum albumin (BSA) as the standard. A total of 50 μg of the samples was heated at 98
• C for 10 min and then subjected to electrophoresis on a 10% SDS-PAGE gel, and the separated proteins were transferred onto nitrocellulose membranes (BioTrace, San Carlos, California). The membranes were blocked in 5% nonfat milk powder prepared in Trisbuffered saline containing 0.1% Tween 20 for 2 h at room temperature and then incubated with primary antibody overnight at 4
• C, including phosphatidylinositol 3-hydroxy kinase (PI3K), serine/threonine protein kinase (Akt), phospho-serine/threonine protein kinase (p-Akt), S6 kinase (S6K), and phosphor-S6 kinase (p-S6K). The primary antibodies and corresponding HRP conjugated secondary antibodies were purchased from Abcam (Shanghai, China) and used at a 1:1000 dilution. The same membrane was incubated with a GADPH (Abcam, Shanghai, China) antibody as an internal control. Finally, the blot was washed and detected by enhanced chemiluminescence (ECL) using the LumiGlo substrate (Pierce, Holmdel, New Jersey) and Clarity Western ECL Substrate (BioRad, Hercules, California).
Statistical analysis
At least 3 replicates were used for each experiment, with results presented as the means ± SEM. The final dataset was analyzed using a MIXED model with 1 CHM: Chinese herbal medicine, including astragalus membranaceus, codonopsis pilosula, poria cocos, bighead atractylodes rhizome, fructus crataegi, folium epimedii, radix saposhnikoviae, and pericarpium citri reticulatae. repeated measures in SAS (SAS Inst. Inc. Cary, NC, release 8.0) to evaluate the effect of CHM treatment on gene expression. Significance or extreme significance at these levels was shown (P < 0.05 or P < 0.01, respectively).
RESULT
Slaughter performance
As shown in Table 2 , the thigh muscle rate was higher in the CHM group than the control group 3.36% (P < 0.01). Compared with the control group, CHM treatment significantly increased the slaughter rate and eviscerated ratio (P < 0.05). Other indexes showed an increasing trend in the CHM group (P > 0.05).
Plasma lipid profile
To explore the relationship between broiler abdominal fat deposition and CHM treatment, we detected the related precursors of TG, TC, and NEFA contents of fat synthesis and some biochemical indexes in plasma. As Table 3 indicates, the results showed that the plasma NEFA content was significantly decreased in both the 0.3% CHM (P < 0.05) and 1% CHM groups (P < 0.01) compared with the control group. Plasma TG content was significantly decreased in the 1% CHM group (P < 0.01) compared with the control group, but the 0.3% CHM group showed a downward trend.
Plasma TC content also showed a downward trend (P > 0.05).
Key enzyme mRNA levels of NEFA synthesis and oxidation in liver
The results showed that SREBP-1c gene expression in the CHM group was significantly more up-regulated than that in the control (P < 0.05), and the downstream gene expression, including SCD, ACC, FAS, and ACSL1, were significantly down-regulated compared to that in the control group (P < 0.05, Figure 1A) . The gene expression levels of PPARα, CPT-1, and LFABP in the CHM group were significantly up-regulated compared to those in the control group (P < 0.01; Figure 1B) . Regarding TAG synthesis, the key mRNA expression levels of the enzymes GPAM, AGPAT6, and LPIN1 were measured and found to be significantly up-regulated ( Figure 1C ). The more abundant GPAM and AGPAT6 mRNA increased by 4-and 6-fold, respectively, in the 1% CHM treatment group.
Expression of the INS/INSR-PI3K-Akt-SREBP-1c pathway in the liver
As shown in Figure 2 , the plasma insulin content was significantly increased (P < 0.05, Figure 2A) , and the gene expression of IR and insulin receptor substrates (IRS) was significantly up-regulated in the CHM group compared to that in the control group (P < 0.05, Figure  2B ). We also found that protein expression levels of PI3K (P < 0.05; Figure 2C ), Akt and P-Akt (P < 0.01, Figure 2D ), and S6K and P-S6K (P < 0.05; Figure 2E ) in the 1% CHM group were higher than those in the control group.
DISCUSSION
PPARα has an important role in the regulation of mitochondrial and peroxisomal fatty acid oxidation, including effects on CPT-I and CPT-II, 2 downstream target genes (Barger and Kelly, 2000; Pettinelli et al., 2011; Koo, 2013) . Sterol regulatory element binding proteins (SREBP) are a key mediator in the control of intracellular lipid metabolism, including the uptake, synthesis, and oxidation of fatty acid in the liver (Foufelle and Ferre, 2002; Shimano, 2002; Chen et al., 2014) . SREBP-1c is one member of this family, and it may regulate many genes such as ACC, SCD, and FAS, which are involved in lipid synthesis and deposition in white adipose tissue, liver, and other tissues (Foufelle and Ferre, 2002; Horton et al., 2003; Lecomte et al., 2010) . To explore the mechanism of the decreased fat content with CHM treatment, we further analyzed a few transcription factors and some key enzymes related to lipid metabolism changes in the liver. The results found that CHM treatment up-regulated the gene expression of SREBP-1c, PPARα, CPT-1, and LFABP, but * P < 0.05 indicates statistically significant differences when compared with the control group. * * P < 0.01 indicates statistically highly significant differences when compared with the control group. The abbreviations are as following: TAG, triacylglycerol; NEFA, nonestesterified fatty acid; and PPARα, peroxisome proliferator activated receptor α.
inhibited the gene expression of the SREBP-1c downstream proteins including SCD, ACC, FAS, and ACSL1. Taken together, these results suggest that CHM treatment promotes NEFA uptake and inhibits NEFA synthesis by regulating the expression of key enzymes in the livers of Hetian broilers. Essentially, CHM treatment reduces NEFA contents and increases NEFA consumption in the liver.
However, TAG synthesis has been discerned in classical lipogenic tissues such as liver and adipose (Coleman and Lee, 2004) . Expression levels of GPAM, AGPAT6, and LPIN1 mRNA were significantly up-regulated (Figure 1B) and they control TG synthesis (Gonzalez-Baro et al., 2007) . The more abundant GPAM and AGPAT6 mRNA agrees with the greater enzyme activity, and confirms its crucial role in TG synthesis (Short et al., 1977; Vernay, 1987) . Despite these differences, we observed that LPIN1 mRNA was up-regulated, which is essential for PPARα protein via protein-protein binding (Finck et al., 2006) . Moreover, it was demonstrated that LPIN1 is a target of insulin stimulated phosphorylation through mTOR, which seems to promote the microsomal vs. cytosolic protein localization (Huffman et al., 2002) . It may be possible that CHM treatment had a significant increase in insulin signaling through IR and IRS1 mRNA expression in the livers of broiler, all of which induces LPIN1 phosphorylation, resulting in TG formation.
Insulin as the key hormone can regulate liver lipid metabolism through the promotion of fatty acid synthesis and inhibits fat catabolism through the PI3K pathway in the liver (Shimomura et al., 2000; Dong and Tang, 2010) . A previous study also found that insulin could promote the FAS gene levels and TG synthesis via the regulation of assembly and secretion of hepatic very low-density lipoprotein (Lewis and Steiner, 1996) . The up-regulated expression of SREBP-1c was achieved via PI3K that was activated after adding insulin to hepatic cells (Foretz et al., 1999) . Lipid synthesis metabolism could be enhanced, as SREBP-1c transcription activity increased after the PI3K-Akt pathway was activated, which was primarily achieved via PI3K signaling to Akt phosphorylation causing the interaction between the downstream phosphorylation cascade reaction and the target protein to regulate transcription factor activity (Porstmann et al., 2005) . In the present research, the plasma insulin level was extremely high after the CHM addition into the base diet. * P < 0.05 indicates statistically significant differences when compared with the control group. * * P < 0.01 indicates statistically highly significant differences when compared with the control group. The abbreviations are as follows: INS, insulin; IR, insulin receptor; IRS, insulin receptor substrates; PI3K, phosphatidylinositol 3-hydroxy kinase; Akt, serine/threonine protein kinase; and SREBP-1c, sterol regulatory element-binding protein-1c.
Additionally, the results showed that the protein levels of the insulin-PI3K-Akt pathway have been increased. Indeed, the upstream PI3K-Akt pathway can activate SREBP-1c. Thus, the SREBP-1c pathway may mediate the effect of CHM on NEFA metabolism towards an enhancement of β-oxidation during fatty acid metabolism in the liver of in Hetian broilers.
In summary, CHM treatment decreases plasma NEFA levels through promoting NEFA oxidation and inhibiting NEFA synthesis in the liver by regulating the expression of key enzymes and the INS/INSR-PI3K-Akt-SREBP1c pathway. Therefore, the CHM used in this study is a compound of potential benefit for decreasing fat synthesis by improving NEFA metabolism.
